Your browser doesn't support javascript.
loading
The KMT2A recombinome of acute leukemias in 2023.
Meyer, C; Larghero, P; Almeida Lopes, B; Burmeister, T; Gröger, D; Sutton, R; Venn, N C; Cazzaniga, G; Corral Abascal, L; Tsaur, G; Fechina, L; Emerenciano, M; Pombo-de-Oliveira, M S; Lund-Aho, T; Lundán, T; Montonen, M; Juvonen, V; Zuna, J; Trka, J; Ballerini, P; Lapillonne, H; Van der Velden, V H J; Sonneveld, E; Delabesse, E; de Matos, R R C; Silva, M L M; Bomken, S; Katsibardi, K; Keernik, M; Grardel, N; Mason, J; Price, R; Kim, J; Eckert, C; Lo Nigro, L; Bueno, C; Menendez, P; Zur Stadt, U; Gameiro, P; Sedék, L; Szczepanski, T; Bidet, A; Marcu, V; Shichrur, K; Izraeli, S; Madsen, H O; Schäfer, B W; Kubetzko, S; Kim, R; Clappier, E.
Affiliation
  • Meyer C; DCAL/Institute of Pharm. Biology, Goethe-University, Frankfurt/Main, Germany.
  • Larghero P; DCAL/Institute of Pharm. Biology, Goethe-University, Frankfurt/Main, Germany.
  • Almeida Lopes B; DCAL/Institute of Pharm. Biology, Goethe-University, Frankfurt/Main, Germany.
  • Burmeister T; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.
  • Gröger D; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Dept. of Hematology, Oncology and Tumor Immunology, Berlin, Germany.
  • Sutton R; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Dept. of Hematology, Oncology and Tumor Immunology, Berlin, Germany.
  • Venn NC; Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.
  • Cazzaniga G; Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.
  • Corral Abascal L; Tettamanti Research Center, Pediatrics, University of Milano-Bicocca/Fondazione Tettamanti, Monza, Italy.
  • Tsaur G; Tettamanti Research Center, Pediatrics, University of Milano-Bicocca/Fondazione Tettamanti, Monza, Italy.
  • Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Emerenciano M; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Pombo-de-Oliveira MS; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.
  • Lund-Aho T; Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.
  • Lundán T; Laboratory of Clinical Genetics, Fimlab Laboratories, Tampere, Finland.
  • Montonen M; Department of Clinical Chemistry and Laboratory Division, University of Turku and Turku University Hospital, Turku, Finland.
  • Juvonen V; Department of Clinical Chemistry and Laboratory Division, University of Turku and Turku University Hospital, Turku, Finland.
  • Zuna J; Department of Clinical Chemistry and Laboratory Division, University of Turku and Turku University Hospital, Turku, Finland.
  • Trka J; CLIP, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Ballerini P; CLIP, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Lapillonne H; Biological Hematology, AP-HP A. Trousseau, Pierre et Marie Curie University, Paris, France.
  • Van der Velden VHJ; Biological Hematology, AP-HP A. Trousseau, Pierre et Marie Curie University, Paris, France.
  • Sonneveld E; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Delabesse E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • de Matos RRC; Institut Universitaire du Cancer de Toulouse, Toulouse Cedex 9, France.
  • Silva MLM; Cytogenetics Department, Bone Marrow Transplantation Unit, National Cancer Institute (INCA), Rio de Janeiro, Brazil.
  • Bomken S; Cytogenetics Department, Bone Marrow Transplantation Unit, National Cancer Institute (INCA), Rio de Janeiro, Brazil.
  • Katsibardi K; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Keernik M; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.
  • Grardel N; Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
  • Mason J; Department of Hematology, CHU Lille, France.
  • Price R; Northern Institute for Cancer Research, Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Mindelsohn Way, Birmingham, United Kingdom.
  • Kim J; Northern Institute for Cancer Research, Newcastle University and the Great North Children's West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Mindelsohn Way, Birmingham, United Kingdom.
  • Eckert C; DCAL/Institute of Pharm. Biology, Goethe-University, Frankfurt/Main, Germany.
  • Lo Nigro L; Department of Laboratory Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Bueno C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Oncology/Hematology, Berlin, Germany.
  • Menendez P; Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico", Catania, Italy.
  • Zur Stadt U; Josep Carreras Leukemia Research Institute. Barcelona, Spanish Network for Advanced Therapies (RICORS-TERAV, ISCIII); Spanish Collaborative Cancer Network (CIBERONC. ISCIII); University of Barcelona, Barcelona, Spain.
  • Gameiro P; Josep Carreras Leukemia Research Institute. Barcelona, Spanish Network for Advanced Therapies (RICORS-TERAV, ISCIII); Spanish Collaborative Cancer Network (CIBERONC. ISCIII); Department of Biomedicine. University of Barcelona; and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona,
  • Sedék L; Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Azienda Policlinico "G. Rodolico", Catania, Italy.
  • Szczepanski T; Pediatric Hematology and Oncology and CoALL Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bidet A; Instituto Português de Oncologia, Departament of Hematology, Lisbon, Portugal.
  • Marcu V; Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland.
  • Shichrur K; Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland.
  • Izraeli S; Laboratoire d'Hématologie Biologique, CHU Bordeaux, Bordeaux, France.
  • Madsen HO; Hematology Laboratory, Sheba Medical Center, Tel-Hashomer, Israel.
  • Schäfer BW; Molecular Oncology Laboratory, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • Kubetzko S; Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kim R; Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Clappier E; Division of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
Leukemia ; 37(5): 988-1005, 2023 05.
Article in En | MEDLINE | ID: mdl-37019990
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Histone-Lysine N-Methyltransferase / Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Histone-Lysine N-Methyltransferase / Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Type: Article Affiliation country: Germany